161 related articles for article (PubMed ID: 12956398)
21. Serotonin enhances beta-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats.
Chi TC; Ho YJ; Chen WP; Chi TL; Lee SS; Cheng JT; Su MJ
Life Sci; 2007 Apr; 80(20):1832-8. PubMed ID: 17397876
[TBL] [Abstract][Full Text] [Related]
22. Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats.
Akhani SP; Vishwakarma SL; Goyal RK
J Pharm Pharmacol; 2004 Jan; 56(1):101-5. PubMed ID: 14980006
[TBL] [Abstract][Full Text] [Related]
23. Acacia nilotica leave extract and glyburide: comparison of fasting blood glucose, serum insulin, beta-thromboglubulin levels and platelet aggregation in streptozotocin induced diabetic rats.
Asad M; Munir TA; Afzal N
J Pak Med Assoc; 2011 Mar; 61(3):247-51. PubMed ID: 21465938
[TBL] [Abstract][Full Text] [Related]
24. Effects of chronic nifedipine treatment on streptozotocin-induced diabetic rats.
Shah TS; Satia MC; Gandhi TP; Bangaru RA; Goyal RK
J Cardiovasc Pharmacol; 1995 Jul; 26(1):6-12. PubMed ID: 7564366
[TBL] [Abstract][Full Text] [Related]
25. Diabetic characteristics and alveolar bone loss in streptozotocin- and streptozotocin-nicotinamide-treated rats with periodontitis.
Kim JH; Lee DE; Choi SH; Cha JH; Bak EJ; Yoo YJ
J Periodontal Res; 2014 Dec; 49(6):792-800. PubMed ID: 24490978
[TBL] [Abstract][Full Text] [Related]
26. Effect of long-term treatment with enalapril in streptozotocin diabetic and DOCA hypertensive rats.
Goyal RK; Satia MC; Bangaru RA; Gandhi TP
J Cardiovasc Pharmacol; 1998 Aug; 32(2):317-22. PubMed ID: 9700996
[TBL] [Abstract][Full Text] [Related]
27. Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats.
Dobrzynski E; Montanari D; Agata J; Zhu J; Chao J; Chao L
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1291-8. PubMed ID: 12424108
[TBL] [Abstract][Full Text] [Related]
28. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats.
Ceylan-Isik A; Hünkar T; Aşan E; Kaymaz F; Ari N; Söylemezoğlu T; Renda N; Soncul H; Bali M; Karasu C;
J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324
[TBL] [Abstract][Full Text] [Related]
29. Effect of Long-Term Diabetes on Serotonin-Mediated Contraction in Carotid Arteries from Streptozotocin-Induced Diabetic Male and Female Rats.
Watanabe S; Matsumoto T; Ando M; Kobayashi S; Iguchi M; Taguchi K; Kobayashi T
Biol Pharm Bull; 2016; 39(10):1723-1727. PubMed ID: 27725452
[TBL] [Abstract][Full Text] [Related]
30. Low molecular weight fucoidan ameliorates streptozotocin-induced hyper-responsiveness of aortic smooth muscles in type 1 diabetes rats.
Liang Z; Zheng Y; Wang J; Zhang Q; Ren S; Liu T; Wang Z; Luo D
J Ethnopharmacol; 2016 Sep; 191():341-349. PubMed ID: 27346541
[TBL] [Abstract][Full Text] [Related]
31. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
Sumiyoshi T; Ichikawa J; Meltzer HY
Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434
[TBL] [Abstract][Full Text] [Related]
32. Effect of chronic treatment with losartan on streptozotocin induced diabetic nephropathy.
Murali B; Goyal RK
Clin Exp Hypertens; 2001 Oct; 23(7):513-20. PubMed ID: 11710753
[TBL] [Abstract][Full Text] [Related]
33. Investigation into the cardiac effects of spironolactone in the experimental model of type 1 diabetes.
Goyal BR; Solanki N; Goyal RK; Mehta AA
J Cardiovasc Pharmacol; 2009 Dec; 54(6):502-9. PubMed ID: 19738487
[TBL] [Abstract][Full Text] [Related]
34. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
[TBL] [Abstract][Full Text] [Related]
35. Beneficial effects of fenoldopam treatment on renal function in streptozotocin-induced diabetic rats.
Umrani DN; Goyal RK
Clin Exp Hypertens; 2002 Apr; 24(3):207-19. PubMed ID: 11883792
[TBL] [Abstract][Full Text] [Related]
36. Effect of sodium selenite treatment on platelet aggregation of streptozotocin-induced diabetic rats.
Ersöz G; Yakaryilmaz A; Turan B
Thromb Res; 2003; 111(6):363-7. PubMed ID: 14698654
[TBL] [Abstract][Full Text] [Related]
37. Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes.
Fernández-González JF; García-Pedraza JÁ; Terol-Úbeda AC; Martín ML; Morán A; García-Domingo M
Biomed Pharmacother; 2024 Jul; 176():116814. PubMed ID: 38820974
[TBL] [Abstract][Full Text] [Related]
38. Effect of sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, on allograft arteriosclerosis after aortic transplantation in rats.
Watada S; Harada H; Matsubara K; Obara H; Matsumoto K; Ando N; Kitagawa Y
Transpl Immunol; 2013 Dec; 29(1-4):162-6. PubMed ID: 23851153
[TBL] [Abstract][Full Text] [Related]
39. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
[TBL] [Abstract][Full Text] [Related]
40. Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin.
Nakamura K; Kariyazono H; Moriyama Y; Toyohira H; Kubo H; Yotsumoto G; Taira A; Yamada K
Blood Coagul Fibrinolysis; 1999 Dec; 10(8):513-9. PubMed ID: 10636463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
